Medical Therapy for Cushing’s Syndrome in the Twenty-first Century
Endocrinology and Metabolism Clinics of North America, ISSN: 0889-8529, Vol: 47, Issue: 2, Page: 427-440
2018
- 19Citations
- 36Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations19
- Citation Indexes19
- 19
- CrossRef16
- Captures36
- Readers36
- 36
Review Description
Medical therapy has a useful adjunctive role in many patients with Cushing's syndrome. Patients with pituitary corticotroph adenomas who have received radiation therapy to the sella require medical therapy until the effects of radiation therapy occur. In addition, patients with Cushing's syndrome who cannot undergo surgery promptly, including those who are acutely ill and cannot safely undergo tumor resection, may benefit from medical therapy as a bridge to surgery. Other possible candidates for medical therapy are those with unresectable tumors or those whose tumor location remains unknown despite adequate diagnostic evaluation.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0889852918300082; http://dx.doi.org/10.1016/j.ecl.2018.01.006; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85045122279&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/29754642; https://linkinghub.elsevier.com/retrieve/pii/S0889852918300082; https://dx.doi.org/10.1016/j.ecl.2018.01.006
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know